Intraocular Tuberculosis—An Update

Gupta, Vishali; Gupta, Amod; Rao, Narsing A.

doi:10.1016/j.survophthal.2007.08.015

Cited by 608 publications

(738 citation statements)

References 198 publications

Supporting

Mentioning

619

Contrasting

Unclassified

Order By: Relevance

“…Extrapulmonary involvement is seen in more than 50% of the patients who have both AIDS and tuberculosis. The risk of extrapulmonary tuberculosis was higher in patients with low CD4+ counts: 70% of the patients with CD4+ counts of less than 100 develop extrapulmonary disease compared to 28% with CD4+ counts of more than 300 [3] .…”

Section: Introductionmentioning

confidence: 92%

See 1 more Smart Citation

Bilateral atypical optic neuritis associated with tuberculosis in an immunocompromised patient

Jaafar¹,

Hitam²,

Noor³

2012

Asian Pacific Journal of Tropical Biomedicine

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 92%

“…It primarily affects the lungs but the proportion of cases with extrapulmonary tuberculosis has increased in recent years in immunocompromised individuals especially in children and females [3] . Extrapulmonary involvement is seen in more than 50% of the patients who have both AIDS and tuberculosis.…”

Section: Introductionmentioning

confidence: 99%

Bilateral atypical optic neuritis associated with tuberculosis in an immunocompromised patient

Jaafar¹,

Hitam²,

Noor³

2012

Asian Pacific Journal of Tropical Biomedicine

View full text Add to dashboard Cite

“…It is relevant that EAU in the mouse cannot be induced without the use of adjuvants, especially MTb extract, since there is an increasing awareness of the role of MTb in a range of uveitis syndromes. 22 …”

Section: Pathology Of Non-infectious Ioi and Correlation With Experimmentioning

confidence: 99%

Bowman lecture on the role of inflammation in degenerative disease of the eye

Forrester

2013

Eye

View full text Add to dashboard Cite

show abstract

“…In cases of doubt, especially in the absence of the diagnosis of a primary malignant site, the differential diagnosis should include other lesions such as granulomas from tuberculosis or sarcoidosis, amelanotic uveal melanomas and lymphomas (28)(29)(30)(31). Ancillary testing with retinal fluorescein angiography may show hyperfluorescence of the mass in the late venous phase.…”

Section: Diagnosismentioning

confidence: 99%

Uveal metastatic disease: Current and new treatment options (Review)

Giuliari¹,

Sadaka²

2011

Oncol Rep

View full text Add to dashboard Cite

Abstract. Choroidal metastasis represents the most common form of intraocular malignancies. It may occur in up to 10% of patients with systemic metastasis with almost half of the patients developing central nervous system disease. The most common primary sites of ocular metastasis are breast cancer in women and lung cancer in men. In most cases, these lesions tend to be asymptomatic and are not evaluated by an ophthalmologist. The diagnosis is generally made by the history of present or prior malignancies and an ophthalmological examination with slit-lamp biomicroscopy and indirect ophthalmoscopy. As with other malignancies, management may vary with each patient. Small tumors, that do not compromise the vision and that have responded previously to systemic treatment, may be closely observed. For larger lesions and for symptomatic ones, external beam radiation offers an excellent alternative to save the eye and stabilize vision. Bevacizumab (Avastin), a potent monoclonal antibody that has also been employed for the treatment of ocular vaso-proliferative diseases, has been used in the treatment of choroidal metastasis and has shown promising results.

show abstract

Intraocular Tuberculosis—An Update

Cited by 608 publications

References 198 publications

Bilateral atypical optic neuritis associated with tuberculosis in an immunocompromised patient

Bilateral atypical optic neuritis associated with tuberculosis in an immunocompromised patient

Bowman lecture on the role of inflammation in degenerative disease of the eye

Uveal metastatic disease: Current and new treatment options (Review)

Contact Info

Product

Resources

About